Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 12, Number 10—October 2006


ICD-9 Codes and Surveillance for Clostridium difficile–associated Disease

Erik Dubberke*Comments to Author , Kimberly Reske*, L. Clifford McDonald†, and Victoria Fraser*‡
Author affiliations: *Washington University in St. Louis–School of Medicine, Saint Louis, Missouri, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ‡Barnes-Jewish Hospital, Saint Louis, Missouri, USA

Main Article

Table 2

Comparison of antimicrobial treatment for Clostridium difficile–associated disease among patient admissions with a positive C. difficile–toxin assay (CDTA+) and patients without a positive toxin assay but with ICD-9 code for C. difficile disease (CDTA–/ICD9+) (categories not mutually exclusive)

Treatment CDTA+, n = 662 (%) CDTA–/ICD9+, n= 239 (%) Odds ratio p value
Any treatment for CDAD 607 (92) 214 (90) 0.78 0.35
Metronidazole 591 (89) 187 (78) 0.43 <0.01
Oral vancomycin 130 (20) 75 (31) 1.87 <0.01
Oral vancomycin and metronidazole 114 (17) 48 (20) 1.21 0.32

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO